News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Paul W. Barone

Advertisement

Articles by Paul W. Barone

The Impact of SARS-CoV-2 on Biomanufacturing Operations

ByPaul W. Barone,Flora J. Keumurian,Michael E. Wiebe,Jacqueline Wolfrum,James C. Leung,Anthony J. Sinskey,Stacy L. Springs
August 4th 2020

This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.

i4-787758-1408598447519.jpg

Correlating Product Lifecycle and Manufacturing Site Characteristics with Critical-to-Quality Product Deviations

ByAnthony J. Sinskey,Jeffrey T. Macher,Paul W. Barone,Reuben D. Domike,Stacy L. Springs,Scott Stern
September 2nd 2012

MIT survey results address product and site characteristics that statistically correlate with quality performance.

Advertisement

Latest Updated Articles

  • The Impact of SARS-CoV-2 on Biomanufacturing Operations
    The Impact of SARS-CoV-2 on Biomanufacturing Operations

    Published: August 4th 2020 | Updated:

  • i4-787758-1408598447519.jpg
    Correlating Product Lifecycle and Manufacturing Site Characteristics with Critical-to-Quality Product Deviations

    Published: September 2nd 2012 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis

2

AAPS PharmSci 360 2025: Trends in Bioanalysis

3

Why Investment Strategies Matter for Advancing Pharmaceutical Technologies

4

PharmTech Weekly News Roundup – Week of November 3, 2025

5

New Dosage Forms and Delivery Systems Driving 505(b)(2) Success

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us